SCH 497079

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Body WeightObesityOverweightType 2 Diabetes Mellitus

Phase 1

Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED)

CompletedNCT00673465

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2008-04-17End: 2008-12-11Updated: 2018-09-10

Phase 2

Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Participants (Study P05483)(COMPLETED)

CompletedNCT00642993

Merck Sharp & Dohme LLCBody Weight, Obesity, Overweight

Start: 2008-06-09End: 2009-01-30Updated: 2018-09-10